Pneumonia in a cardiothoracic intensive care unit: incidence and risk factors

J Cardiothorac Vasc Anesth. 2009 Dec;23(6):780-8. doi: 10.1053/j.jvca.2009.03.019. Epub 2009 Jun 4.

Abstract

Objective: The purpose of this study was to determine the incidence, risk factors, and pathogens causing pneumonia in a cardiothoracic intensive care unit (CTICU).

Design: A prospective study.

Setting: "Civili Hospital," Brescia, Italy.

Participants: One hundred forty consecutive patients in the CTICU for more than 24 hours from October 1, 2006, to September 30, 2007.

Interventions: None.

Measurements and main results: Demographic variables and intrinsic and extrinsic risk factors were analyzed with univariate and multivariate analysis. One hundred forty patients were studied, 128 (91.4%) were surgical and 12 (8.5%) were medical. Cumulative incidence of pneumonia was 28.6% (n = 40); 62.5% (n = 25) had ventilator-associated pneumonia (VAP) and 37.5% (n = 15) had non-VAP. The most common isolated pathogens were Pseudomonas aeruginosa (n = 15), Staphylococcus aureus (n = 5), Escherichia coli (n = 4), and Klebsiella pneumoniae (n = 3). Mortality was 22.2% (n = 31), with 54.8% (n = 17) of patients with pneumonia leading to mortality during CTICU stay (p = 0.0006). On multivariate analysis, independent risk factors for pneumonia were each point of the Sequential Organ Failure Assessment score at CTICU admission (p = 0.006, odds ratio [OR] = 1.39, confidence interval [CI] = 1.09-1.76), every day of mechanical ventilation (p = 0.049, OR = 1.08, CI = 1.00-1.18), noninvasive mechanical ventilation (NIMV) (p = 0.014, OR = 4.83, CI = 1.37-17.03), and bronchoscopy (p = 0.002, OR = 8.14, CI = 2.10-31.55).

Conclusions: Pneumonia is a common complication in the CTICU, and the authors recommend the following: the removal of the endotracheal tube as soon as possible, the minimal use of a bronchoscope and only in cases of bronchial obstruction, and the use of NIMV.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Bronchoscopes / adverse effects*
  • Clinical Protocols
  • Escherichia coli / isolation & purification
  • Female
  • Humans
  • Incidence
  • Intensive Care Units*
  • Klebsiella pneumoniae / isolation & purification
  • Male
  • Middle Aged
  • Pneumonia* / epidemiology
  • Pneumonia* / microbiology
  • Pneumonia* / prevention & control
  • Pneumonia, Ventilator-Associated / epidemiology
  • Pneumonia, Ventilator-Associated / microbiology
  • Prospective Studies
  • Pseudomonas aeruginosa / isolation & purification
  • Respiration, Artificial / adverse effects*
  • Risk Factors
  • Staphylococcus aureus / isolation & purification
  • Thoracic Surgical Procedures*
  • Treatment Outcome
  • Young Adult